Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2013. Start Trial.
Date Value
November 30, 2025 0.0443M
November 30, 2024 -0.0884M
November 30, 2023 -0.2852M
November 30, 2022 -0.114M
November 30, 2021 -0.4904M
November 30, 2020 -0.6418M
November 30, 2019 -2.459M
Date Value
November 30, 2018 -1.514M
November 30, 2017 -1.089M
November 30, 2016 -0.8473M
November 30, 2015 -0.7263M
November 30, 2014 -0.9892M
November 30, 2013 -0.401M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Medifast, Inc. 6.863M
Integrated BioPharma, Inc. 2.065M
BioForce Nanosciences Holdings, Inc. -0.0652M
Skinvisible, Inc. -0.0384M
Skinhealth Systems, Inc. 37.48M